期刊文献+

血浆脂蛋白相关磷脂酶A2对慢性肾脏病患者心血管事件的预测价值

Value of Plasma Lipoprotein Associated Phospholipase A2 in Predicting Cardiovascular Events in Patients with Chronic Kidney Disease
下载PDF
导出
摘要 目的:探讨血浆脂蛋白相关磷脂酶A2(LP-PLA2)对慢性肾脏病(CKD)患者心血管事件的预测价值。方法:回顾性分析2013年7月-2017年11月在东莞东华医院治疗的200例CKD患者资料。收集所有患者血清指标,包括总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、甲状旁腺激素(PTH)、超敏C反应蛋白(hs-CRP)、缺血修饰白蛋白(IMA)、肌钙蛋白T(cTnT)、LP-PLA2含量,并采用Framingham评分系统评估所有患者心血管疾病风险。根据LPPLA2检测结果将患者分为高LP-PLA2组和正常LP-PLA2组,比较两组一般资料、血清指标、Framingham评分及主要心血管不良事件(MACE)的发生情况。采用Pearson检验分析LP-PLA2与血清指标、Framingham评分的相关性,绘制ROC曲线分析LP-PLA2对CKD患者MACE的预测价值。结果:高LP-PLA2组年龄大于正常LP-PLA2组,且高血压、心血管病史的占比高于LP-PLA2组(P<0.05)。高LP-PLA2组患者HDL-C低于正常LP-PLA2组,PTH、hs-CRP、IMA、cTnT、Framingham评分高于正常LP-PLA2组(P<0.05)。LP-PLA2与HDL-C呈负相关(r=-0.436,P<0.05),与PTH、hs-CRP、IMA、cTnT、Framingham评分呈正相关(r=0.377、0.628、0.566、0.382、0.572,P<0.05)。高LP-PLA2组的MACE发生率为35.2%(25/71),高于正常LP-PLA2组的11.7%(13/112)(P<0.05)。ROC曲线分析显示,LP-PLA2预测MACE的曲线下面积为0.880(95%CI:0.810,0.950)。结论:LP-PLA2可能与CKD患者冠脉病变密切相关,通过监测LP-PLA2水平变化对MACE的发生具有显著的预测价值。 Objective:To explore the value of plasma lipoprotein associated phospholipase A2(LP-PLA2)in predicting cardiovascular events in patients with chronic kidney disease(CKD).Method:A total of 200 patients with CKD treated in Dongguan Donghua Hospital from July 2013 to November 2017 were analyzed retrospectively.Serum indexes including total cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C),parathyroid hormone(PTH),high sensitivity C-reactive protein(hsCRP),ischemia modified albumin(IMA),troponin T(cTnT)and LP-PLA2 were measured.The risk of cardiovascular disease was evaluated by Framingham scoring system.According to the results of LP-PLA2 test,the patients were divided into high LP-PLA2 group and normal LP-PLA2 group.The basic data,serum indexes,Framingham score and the incidence of major adverse cardiovascular events(MACE)were compared between the two groups.Pearson test was used to analyze the correlation between LP-PLA2,serum indexes and Framingham score,and ROC curve was drawn to analyze the predictive value of LP-PLA2 on MACE in patients with CKD.Result:The age of high LP-PLA2 group was older than that in normal LP-PLA2 group,and the proportion of hypertension and cardiovascular history was higher than that in LP-PLA2 group(P<0.05).HDL-C in high LP-PLA2 group was lower than that in normal LP-PLA2 group,and PTH,hs-CRP,IMA,cTnT and Framingham scores were higher than those in normal LP-PLA2 group(P<0.05).LP-PLA2 was negatively correlated with HDL-C(r=-0.436,P<0.05),and positively correlated with PTH,hs-CRP,IMA,cTnT and Framingham score(r=0.377,0.628,0.566,0.382,0.572,P<0.05).The incidence of MACE in high LP-PLA2 group was 35.2%(25/71),which was higher than 11.7%(13/112)in normal LP-PLA2 group(P<0.05).ROC curve analysis showed that the area under the curve of MACE predicted by LPPLA2 was 0.880(95%CI:0.810,0.950).Conclusion:LP-PLA2 may be closely related to coronary artery disease in patients with CKD.Monitoring the level of LP-PLA2 has significant predictive value for MACE.
作者 丁苏 周蓉 谢应业 章梦璧 李爱婷 DING Su;ZHOU Rong;XIE Yingye;ZHANG Mengbi;LI Aiting(Dongguan Donghua Hospital,Dongguan 523000,China;不详)
机构地区 东莞东华医院
出处 《中外医学研究》 2022年第16期80-84,共5页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 东莞市社会科技发展(一般)项目(201950715046315)。
关键词 脂蛋白相关磷脂酶A2 慢性肾脏病 主要心血管不良事件 冠脉病变 Lipoprotein associated phospholipase A2 Chronic kidney disease Major adverse cardiovascular events Coronary artery disease
  • 相关文献

参考文献10

二级参考文献69

  • 1杨建伯.中国人口平均寿命及流行病学意义[J].中国地方病学杂志,2003,22(2):137-140. 被引量:14
  • 2刘靖,杨靓,孙宁玲,马济顺,胡大一.微量白蛋白尿及假性血友病因子与高血压代谢综合征的关系[J].北京大学学报(医学版),2007,39(6):587-590. 被引量:2
  • 3BAROR D, LAU E, RAO N, et al. Reduction in cobalt binding capacity of human albumin with myocardial ischemia [ J ]. Ann Emerg Med, 1999, 34(Suppl) : 56.
  • 4BHAGAVAN N V, LAI E M, RIOS P A. Evaluation of human se- rum albumin cobalt binding assay for the assessment of myocardial is chemia and myocar- dial infarction[ J]. Clin Chen, 2003, 49 (4) : 581 -585.
  • 5ROY D, QUILES J, ALDAMA G, et al. Ischemia modified albu- min for the assessment of patients presenting to the emergency de- partment with acute ehest pain but nondiagnostic 12 lead electro- cardiograms and negative cardiactroponin T [ J ]. Int J Cardiol, 2004, 97(2) : 297 -301.
  • 6Oei H H, Vander Meer IM, ttofman A, et al. I.ipoprotein-associat- e3 phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the rotterdam study[J]. Circu lation, 2005,111 (5) : 570-575.
  • 7Winkler K, Hoffmann MM, Winkelmann BR, et al. Lipoprotein associated phospholipase A2 predicts 5 year cardiac mortality in- dependently of established risk factors and adds prognostic infor marion in patients with low and medium high sensitivity C-reac- tive protein[J]. Clin Chem,2007,53(8) : 1440 -1447.
  • 8Garza CA, Montori VM, McConnell JP, et al. Association between IApoprotein-associated phospholipase A2 and cardiovascular dis- ease:a systematic review[J]. Mayo Clin Proc, 2007,82 (2) : 159- 165.
  • 9Papathanasiou AI, Lourida I.D, et al. Short-and long term eleva- tion of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein associated phospholipase A2 and the effect of atorvastatintreatment[J]. A therosclerosis,2008,196(2) :289 -297.
  • 10Anuurad E,Ozturk Z,Enkhmaa B,et al. Association of l.ipopro- rein-associated phospholipase A2 with coronary artery disease in african Americans[J]. Clin Endocrinol, 2010,95 ( 23 ) : 2376-2383.

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部